Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population

Clinical Genetics

Volumn 80, Issue 4, 2011, Pages 375-382

  Pertesi, M ^a   Konstantopoulou, I ^a   Yannoukakos, D ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

BRCA1; Founder mutation; Haplotype analysis; Large genomic rearrangements

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENOMICS; GREECE; HAPLOTYPE; HUMAN; ONCOGENE; PRIORITY JOURNAL; SHORT TANDEM REPEAT;

ADULT; ALLELES; BREAST NEOPLASMS; EXONS; FEMALE; FOUNDER EFFECT; GENES, BRCA1; GERM-LINE MUTATION; GREECE; HAPLOTYPES; HUMANS; MICROSATELLITE REPEATS; MIDDLE AGED; MUTATION; OVARIAN NEOPLASMS; PEDIGREE;

EID: 80052612571     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01532.x     Document Type: Article

References (31)

1. Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990: 250: 1684-1689.
2. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994: 266: 66-71.
3. Puget N, Torchard D, Serova-Sinilnikova OM et al. A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17. Cancer Res 1997: 57: 828-831.
4. Mazoyer S. Genomic rearrangements in the BRCA1 and BRCA2 genes. Hum Mutat 2005: 25: 415-422 (Review).
5. Sluiter MD, van Rensburg EJ. Large genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutation. Breast Cancer Res Treat 2010 (e-pub ahead of print).
6. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997: 60: 1013-1020.
7. Ferla R, Calò V, Cascio S et al. Founder mutations in BRCA1 and BRCA2 genes. Ann Oncol 2007: 18(Suppl 6): vi93-vi98 (Symposium Article).
8. Tonin P, Serova O, Lenoir G et al. BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 1995: 57: 189.
9. Neuhausen SL, Mazoyer S, Friedman L et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 1996: 58: 271-280.
10. Peelen T, Cornelis RS, van Vliet M et al. The majority of 22 Dutch high-risk breast cancer families are due to either BRCA1 or BRCA2. Eur J Hum Genet 1996: 4: 225-230.
11. Tonin PN, Mes-Masson AM, Futreal PA et al. Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families. Am J Hum Genet 1998: 63: 1341-1351.
12. Bergthorsson JT, Jonasdottir A, Johannesdottir G et al. Identification of a novel splice-site mutation of the BRCA1 gene in two breast cancer families: screening reveals low frequency in Icelandic breast cancer patients. Hum Mutat 1998: (Suppl 1): S195-S197.
13. Møller P, Heimdal K, Apold J et al. Genetic epidemiology of BRCA1 mutations in Norway. Eur J Cancer 2001: 37: 2428-2434.
14. Górski B, Jakubowska A, Huzarski T et al. A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 2004: 110: 683-686.
15. Anagnostopoulos T, Pertesi M, Konstantopoulou I et al. G1738R is a BRCA1 founder mutation in Greek breast/ovarian cancer patients: evaluation of its pathogenicity and inferences on its genealogical history. Breast Cancer Res Treat 2008: 110: 377-385.
16. Smith TM, Lee MK, Szabo CI et al. Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res 1996: 6: 1029-1049.
17. Gu W, Zhang F, Lupski JR. Mechanisms for human genomic rearrangements. Pathogenetics 2008: 1: 4.
18. Puget N, Gad S, Perrin-Vidoz L et al. Distinct BRCA1 rearrangements involving the BRCA1 pseudogene suggest the existence of a recombination hot spot. Am J Hum Genet 2002: 70: 858-865.
19. Petrij-Bosch A, Peelen T, van Vliet M et al. BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients. Nat Genet 1997: 17: 341-345.
20. Hartmann C, John AL, Klaes R et al. Large BRCA1 gene deletions are found in 3% of German high-risk breast cancer families. Hum Mutat 2004: 24: 534.
21. Hansen TO, Jønson L, Albrechtsen A et al. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families. Breast Cancer Res Treat 2009: 115: 315-323.
22. Weitzel JN, Lagos VI, Herzog JS et al. Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 2007: 16: 1615-1620.
23. Ticha I, Kleibl Z, Stribrna J et al. Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene. Breast Cancer Res Treat 2010.
24. The BRCA1 Exon 13 Duplication Screening Group. The exon 13 duplication in the BRCA1 gene is a founder mutation present in geographically diverse populations. Am J Hum Genet 2000: 67: 207-212.
25. Belogianni I, Apessos A, Mihalatos M et al. Characterization of a novel large deletion and single point mutations in the BRCA1 gene in a Greek cohort of families with suspected hereditary breast cancer. BMC Cancer 2004: 4: 61.
26. Armaou S, Konstantopoulou I, Anagnostopoulos T et al. Novel genomic rearrangements in the BRCA1 gene detected in Greek breast/ovarian cancer patients. Eur J Cancer 2007: 43: 443-453.
27. Konstantopoulou I, Rampias T, Ladopoulou A et al. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients. Breast Cancer Res Treat 2008: 107: 431-441.
28. Armaou S, Pertesi M, Fostira F et al. Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases. Br J Cancer 2009: 101: 32-37.
29. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988: 16: 1215.
30. Fan H, Chu JY. A brief review of short tandem repeat mutation. Genomics Proteomics Bioinformatics 2007: 5 (1): 7-14 (Review).
31. Kruglyak S, Durrett RT, Schug MD et al. Equilibrium distributions of microsatellite repeat length resulting from a balance between slippage events and point mutations. Proc Natl Acad Sci USA 1998: 95 (18): 10774-10778.